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Abstract
Objective: To report the incidence rates of TB and HIV in household contacts of index patients diagnosed with TB.
Design: A prospective cohort study in the Matlosana sub-district of North West Province, South Africa.
Methods: Contacts of index TB patients received TB and HIV testing after counseling at their first household visit and were
then followed up a year later, in 2010. TB or HIV diagnoses that occurred during the period were determined.
Results: For 2,377 household contacts, the overall observed TB incidence rate was 1.3 per 100 person years (95% CI 0.9–1.9/
100py) and TB incidence for individuals who were HIV-infected and HIV seronegative at baseline was 5.4/100py (95% CI 2.9–
9.0/100py) and 0.7/100py (95% CI 0.3–1.4/100py), respectively. The overall HIV incidence rate was 2.2/100py (95% CI 1.3–8.4/
100py).
Conclusions: In the year following a household case finding visit when household contacts were tested for TB and HIV, the
incidence rate of both active TB and HIV infection was found to be extremely high. Clearly, implementing proven strategies
to prevent HIV acquisition and preventing TB transmission and progression to disease remains a priority in settings such as
South Africa.
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Background
South Africa has an estimated annual tuberculosis (TB)
incidence rate of 1.0 per 100 population (95% CI 0.8–1.2) [1].
This is largely fuelled by a severe and generalised human
immunodeficiency virus (HIV) epidemic, which continues to be
propagated by HIV incidence of 1.3 per 100 susceptible
individuals per annum in 15–49 year olds [2]. There are several
studies from high burden countries describing the prevalence of
HIV and TB in contacts of TB index cases, but few describe TB
incidence over a prospective follow up period, and none, that we
are aware of, where HIV incidence was determined simultaneous-
ly [3,4,5,6]. Incidence measures of both TB and HIV are
important for those planning or implementing household-based
active case finding strategies, which have shown some promise in
controlling TB [7,8], and for policy makers to base decisions on
the utility of a second or third visit to the household of an index
TB patient. They are also critical in estimating sample sizes for
clinical trials of preventive treatment in household contacts. This
study describes the incidence of TB and HIV in household
contacts of TB index patients in a very high TB and HIV burden
setting.
Methods
Ethics Statement
This study was approved by the ethics committees of the
University of the Witwatersrand, the Research Committee of the
Klerksdorp/Tshepong Hospital Complex, and the Johns Hopkins
School of Medicine institutional review board. All study partic-
ipants gave individual written informed consent for study
participation. Written parental consent was obtained for all
participants younger than 18, with assent from 7–17 year olds.
Separate written consent for on-site rapid HIV testing or oral
specimen collection for HIV testing was obtained.
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Study setting
This prospective cohort study was conducted in the households
of index TB patients in the Matlosana sub-district in North West
Province. TB patients were recruited from the adult internal
medicine wards of the only public sector regional hospital serving
the sub-district, and from the 16 primary care clinics within the
sub-district. The entire district within which Matlosana is situated,
is estimated to have an annual TB incidence of close to 1.2 per 100
person years (personal communication L. Mvusi) and HIV
seroprevalence of 29% [9] in pregnant women. The HIV
seroprevalence in South Africa among all persons aged 15–49
was 17.9% in 2012 [10].
Baseline study visit
We recruited index TB patients into a study that previously
reported the prevalence of undiagnosed TB and HIV in contacts
of adult TB index cases recruited at a regional hospital and its
feeder clinics [11]. Patients were eligible if they were admitted to
hospital with a diagnosis of TB, irrespective of the presence of
laboratory confirmation but, if recruited from a community clinic,
they were required to be sputum smear positive.
Households had a baseline first visit between February and
November 2009. At that visit, individually consenting household
members were offered on-site rapid HIV testing after counselling;
those who were found to be HIV-infected had post-test counselling
and a blood draw for CD4 count to be analysed at the study
laboratory. Children aged 18 months and older were tested for
HIV, unless a result from a recent test was available. Those 0–18
months old were tested for HIV using DNA PCR methods, if their
mothers were HIV positive. We report the total TB and HIV
prevalence at that visit including both already diagnosed cases and
patients diagnosed for the first time at the initial study visit.
All those who could provide a sputum sample had one taken for
auramine smear and mycobacterial growth indicator tube (MGIT)
culture - irrespective of the presence of symptoms suggestive of
TB. Children who could not produce sputum were referred to the
clinic for further investigation. TB and CD4 results were provided
to the households at a visit about six weeks after the baseline visit.
All index cases and household contacts who tested HIV positive
were referred for either isoniazid preventative therapy (IPT) and/
or antiretroviral therapy (ART). Those who had TB disease were
referred for TB treatment and children under five were referred
for assessment to their nearest clinic.
Follow-up study visit
We now report the findings of a second study visit in 2010 made
to the same households approximately one year after the first. All
participants who were able to be re-contacted were individually
asked whether they had been diagnosed with HIV or TB in the
period between visits. If a positive response was received the date
of diagnosis was elicited. Patient-held TB treatment cards were
used to verify TB treatment occurring between visits. If a
household member had died in the interim, we asked about the
cause of death. All surviving participants had a standardised TB
symptom screen performed at the second visit. Those with
symptoms of TB had a sputum sample taken for smear and
culture. Smears were examined under polarised light after
auramine staining and sputum samples were cultured in liquid
medium using the mycobacterial growth indicator tube system
(Becton Dickenson Franklin Lakes, NJ). All baseline HIV
seronegative individuals - including those reporting seroconversion
between study visits - were offered rapid, on site HIV testing or
laboratory ELISA HIV testing on blood or saliva specimens.
Inclusion criteria
For the TB prevalence and incidence analyses, we only included
household contacts who had a sputum result or were on TB
treatment at their first study visit and who either died in the
intervening year or were able to be contacted at the second visit.
No index TB cases were included in the prevalence or prospective
analysis. Incident TB was defined either as a new diagnosis of TB,
neither present at the first household visit, nor diagnosed within 60
days following that first study visit. We also included as incident
cases, contacts whose relatives reported that they died of TB in the
intervening time. Those with prevalent TB at the first visit were
considered to have an incident episode only if they were diagnosed
with TB at least 8 months after the prior TB diagnosis.
Household contacts who tested negative for HIV at the first visit
and had a follow up test at the second visit were included in the
HIV incidence calculation. Incident HIV infections were defined
as participants with a negative HIV rapid test at baseline and a
positive HIV rapid test and/or laboratory HIV test one year later.
Those who reported being tested HIV-infected between the first
and final visits had a confirmatory rapid test at the second visit.
HIV seroconversions were assumed to have happened at
uniformly distributed times between first and second visits. Similar
to the first study visit a year earlier, any participant at this second
study visit who was diagnosed with HIV had an immediate CD4
count taken and then referred for either IPT or ART initiation
depending on their CD4 count; those with positive auramine
smear or mycobacterial culture were referred for initiation of TB
treatment.
Statistical methods
The sample size of this study was based on a TB prevalence
survey [11] and was not designed to provide precise estimates of
incidence rates or compare incidence rates between groups. For
this reason, only descriptive statistics are reported. The binomial
exact method was used to calculate 95% confidence intervals for
the incidence and prevalence estimates.
Results
Of 2,843 household contacts assessed at baseline, 2,337 (82%)
were re-contacted at a median time of 360 days (IQR 341–404
days) after the first visit; 40 contacts died in the intervening period.
The ratio of females to males at the baseline visit and
approximately one year later was 1.37 and 1.44, respectively
(p = 0.39). The median age of all participants at baseline was 18
years (IQR 8–34) and that of those re-assessed a year later was also
18 years (IQR 9–38). At both visits 42% of contacts were 0–14
years old. The 670 households of a TB index case had a median of
4 windows and 2 doors and the median household size was 5
people (IQR 3–7) per household.
Baseline TB and HIV prevalence
Baseline total TB prevalence for the 2,377 household contacts
who were revisited or had died in the meantime, was 9.2% (95%
CI 8.0–10.5%). These cases were either found by active case
finding or were already on TB treatment at the time of the first
study visit. Similarly, total HIV prevalence at the first visit was
17.9% (95% CI 16.0–20.0%). TB prevalence among HIV-infected
participants was 10.6% (95% CI 7.2–15.0%) and HIV prevalence
among TB patients was 24.3% (95% CI 16.8–33.2%).
Mortality
Of 40 household contacts who died in the intervening period
between study visits, 11/23 (48%) were HIV-infected at baseline.
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Eight of the 40 (20%) reportedly died of TB or while on TB
treatment; four of the eight tested for HIV at baseline and two of
the four were HIV-infected.
TB incidence
Overall, there were 26 incident TB cases in 2,089 people who
had a documented culture result at baseline and who were
followed up at the second study visit a year later (22), or died in the
intervening period (4). Cumulative follow up time was 1,960 years
during which 24 incident TB cases occurred in the time between
the study visits, a median time of 170 days after the first study visit.
A further two TB cases were diagnosed at the second household
visit (Figure 1). The overall observed incidence rate of TB was
therefore 1.3 per 100 person years (/100py) (95% CI 0.9–1.9/
100py); that for individuals who were HIV-infected and HIV
seronegative at baseline was 5.4/100py (95% CI 2.9–9.0/100py)
and 0.7/100py (95% CI 0.3–1.4/100py), respectively. TB
incidence rate for males and females was 1.4/100py (95% CI
0.7–2.5/100py) and 1.3/100py (95% CI 0.7–2.1/100py), respec-
tively. The peak age group for TB was 35–54 year olds with an
incidence rate of 2.4/100py (95% CI 1.0–4.7/100py). TB
incidence rate for children 0–14 years of age and adults aged 15
and above were 1.2/100py (95% CI 0.5–2.3/100py) and 1.4/
100py (95% CI 0.8–2.2/100py) respectively. A positive smear
result in the index case appeared to show higher risk of incident
TB (Table 1). Of 53 HIV infected household contacts who were
referred for IPT at the baseline visit, 16 (27.1%) reported at the
second visit that they received IPT. Two of those who were
referred for IPT but did not take it, had an incident TB episode.
None of 115 household contacts who reported that they received
IPT since the first visit had an incident episode of TB.
When we included household contacts who did not have a
sputum taken for auramine smear and MGIT culture at baseline
in the incidence calculation - assuming them to be TB negative at
baseline - the overall TB incidence rate was also 1.3/100py (95%
CI 0.9–1.8/100py).
HIV Incidence
Of the 1,472 household contacts HIV-tested at baseline, 1,208
were HIV seronegative. Of the HIV seronegative contacts, 815
(67%) were tested again at the second household visit (Figure 2).
There were 18 seroconversions in this group and 823 person years
of exposure time, reflecting an overall HIV incidence rate of 2.2/
100py (95% CI 1.3–8.4/100py). Twelve females and six males had
a documented seroconversion, reflecting an HIV incidence rate of
2.5/100py (95% CI 1.3–4.3/100py) and 1.8/100py (95% CI 0.7–
3.8/100py), respectively. The peak incidence rate was in the age
stratum 35–54 years at 3.7/100py (95% CI 1.0–9.2/100py).
Higher HIV seroconversion rates occurred in households with
fewer people per room (Table 1).
Of note, 265 of 905 (29%) participants who refused HIV testing
at the baseline visit agreed to HIV testing at the second household
visit - 20 (7.5%) were HIV-infected. These participants were not
included in incidence calculations. Fourteen contacts were referred
for ART at the first study visit – 4 reported that they had started
ART.
Discussion
In the year following an intensified case finding visit for TB and
HIV, approximately 1.3/100py and 2.2/100py of household
contacts of TB index cases developed TB, or were newly infected
with HIV, respectively. Although subsequent cases of TB may
have been reduced by the single intensified case finding strategy as
has previously been suggested [12], the point estimate of annual
TB incidence rate in contacts of index TB cases we report is still
higher than the population level estimate of incidence for the
entire district based on TB notifications in 2009. TB incidence rate
among HIV-infected individuals we found in this study – 5.4/
100py - is similar to the incidence rate reported in a clinical cohort
of HIV-infected individuals not taking antiretrovirals in Soweto,
about 120km from Matlosana - 4.7/100py (95% CI 4.0–5.8) [13].
The point estimate of HIV incidence in retested participants we
report was also high when compared to the modelled HIV
incidence estimate for North West Province in 2010 which was
0.79% for the general population [14]. This, despite participants
receiving HIV counselling and testing one year previously -
counselling and HIV testing has been shown to reduce sexual risk
behaviour in discordant couples [15,16]. Moreover, this health
sub-district has a well-functioning antiretroviral program with,
reportedly, over 30,000 individuals receiving HAART, and free-of
Figure 1. TB results of household contacts at the first household visit and at the second household visit. * Household contacts who
were found again at follow-up visit or who died between visits were included in this study.
doi:10.1371/journal.pone.0095372.g001
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Table 1. TB incidence and HIV incidence by individual and household-level sociodemographic characteristics of the cohort of
household contacts of TB index cases in a high HIV prevalent and TB burden setting.
Total (N=2377) TB Incidence (N=2089) HIV Incidence (N=815)
N % N per 100py 95% CI N per 100py 95% CI
Total 2377 26 1.3 0.9–1.9 18 2.2 1.3–3.4
Individual-level characteristics
Sex
Female 1403 59% 15 1.3 0.7–2.1 12 2.5 1.3–4.3
Male 974 41% 11 1.4 0.7–2.5 6 1.9 0.7–3.8
Age category
0–14 1004 42% 8 1.2 0.5–2.3 2 0.7 0.1–2.6
15–34 716 30% 5 0.8 0.2–1.8 9 3.1 1.4–5.7
35–54 358 15% 8 2.4 1.0–4.7 4 3.7 1.0–9.2
55+ 299 13% 5 1.8 0.6–4.2 3 2.1 0.4–6.0
Education
none 706 30% 5 1.2 0.4–2.9 5 2.8 0.9–6.4
primary/secondary/tertiary 1660 70% 21 1.4 0.8–2.1 13 2.0 1.1–3.5
missing 11 0% 0 0
Employment
Student/minor 1273 54% 8 0.9 0.4–1.7 5 1.2 0.4–2.7
Employed (formal/informal) 202 9% 3 1.5 0.3–4.4 3 4.4 0.9–12.2
Unemployed/able 559 24% 9 1.7 0.8–3.3 8 4.2 1.8–8.0
Pensioner/unable to work 302 13% 5 1.8 0.6–4.2 2 1.5 0.2–5.2
missing 41 1% 1 0
Household-level characteristics
Number of people in household
2–4 560 24% 8 1.7 0.7–3.4 7 3.9 1.6–7.8
5–7 952 40% 10 1.3 0.6–2.3 5 1.6 0.5–3.7
8+ 865 36% 8 1.1 0.5–2.2 6 1.8 0.7–3.9
Housetype
House/Other 1786 75% 16 1.1 0.6–1.7 13 2.1 1.1–4.2
Shack 580 24% 10 2.1 1.0–3.9 5 2.4 0.8–5.6
missing 11 0% 0
Average number of people per room
0–1 583 25% 7 1.4 0.6–2.9 5 2.4 0.8–5.5
1–2 1032 43% 9 1.2 0.5–2.1 8 2.4 1.0–4.7
.2 762 32% 10 1.3 0.8–2.9 5 1.8 0.6–4.1
Signs of indoor smoking
No 2255 95% 24 1.3 0.8–1.9 17 2.2 1.3–1.4
Yes 117 5% 2 2.7 0.3–9.4 1 2.8 0.1–14.9
missing 5 0% 0 0
Index smear result
Negative 300 13% 5 2.0 0.6–4.5
Scanty 107 5% 2 2.2 0.3–7.7
Moderate 195 8% 4 2.5 0.7–6.3
Numerous 291 12% 6 2.5 0.9–5.4
Not available/not performed 1484 62% 9 0.7 0.3–1.4
Household-level characteristics are features of the household or index relative to each contact.
doi:10.1371/journal.pone.0095372.t001
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charge condoms are widely available at all 16 primary care
community clinics, making the high HIV incidence we report
particularly concerning.
Although a relatively large number of individuals were followed
up, the sample size was too small to identify statistically significant
risk factors for either incident TB or HIV, illustrating the large
sample sizes required for studies with short follow up - even in high
HIV incidence and high TB burden settings - to identify risk
factors for TB disease and acquiring HIV infection. A second
limitation is that two different TB case finding strategies were used
at the first and second household visits and additional incident
cases might have been identified if all participants – irrespective of
TB symptomatology - had been asked to provide a sputum
specimen for smear and mycobacterial culture, as was done at the
first study visit when only 11% of TB cases were symptomatic. A
third limitation is that no genotyping was done to link
transmissions between cases and household contacts. Fourthly,
refusal rates for HIV testing were high at both visits, 39% at first
visit and 32% at the second visit, which may have resulted in
biased estimates of HIV prevalence and incidence. Finally, the
environment has altered since our study. Examples of improve-
ments are: better TB diagnostics are available, more people have
been started on antiretroviral therapy, and more HIV-infected
adults are receiving IPT [17]. If the study were to be repeated
now, lower HIV and TB incidence may be recorded. We therefore
recommend that studies such as this be repeated cyclically to
demonstrate implementation effectiveness of HIV and TB related
interventions.
The high incidence rates of both HIV and TB found in this
study suggest urgent action is required to control TB transmission,
to prevent TB disease and to prevent new HIV infections. We
posit that the efficacy of contact tracing for TB control purposes
might be improved by a second intensified case finding visit and by
providing preventive treatment against TB for both HIV-infected
and HIV-seronegative contacts; this would of course have major
cost implications. Earlier diagnosis of HIV with initiation of
antiretroviral therapy at diagnosis will assist in preventing new
HIV infections and TB cases [18]; but methods of encouraging
cyclical HIV retesting [19] and ensuring linkages to care must be
rigorously assessed before widespread implementation. Finally,
there is a need for similar studies of TB and HIV incidence both in
contacts of TB cases and in other populations to better understand
TB and HIV transmission dynamics and to infer effectiveness of
interventions to curb both epidemics.
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